Clinical Trials Browser

Anus Neoplasms

NCT04907643 2026-02-20

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Cancer Pain, Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms, Carcinoid Tumor, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Stomach Neoplasms, Neuroendocrine Tumors, Visceral Pain

NCT05838391 2026-02-03

Adaptive Radiation in Anal Cancer

Phase NA Recruiting

20 enrolled

Gastrointestinal

Anus Neoplasms

NCT07112690 2026-01-30

Ganglion Impar Neurolysis for the Improvement of Radiation-Induced Pain During Localized Anal or Perianal Skin Cancer Treatment

Phase NA Recruiting

5 enrolled

Gastrointestinal

Anus Neoplasms

NCT07192055 2026-01-12

SOLO

Phase NA Recruiting

572 enrolled

Gastrointestinal

Anus Neoplasms

NCT07029152 2025-11-18

SCOPE

Phase NA Recruiting

296 enrolled

GastrointestinalGynecologic

Squamous Intraepithelial Lesions, Anus Neoplasms, Carcinoma, Squamous Cell, Homosexuality

NCT03958240 2025-09-15

DECIDE

Phase NA Recruiting

1,100 enrolled

GastrointestinalGynecologicHead & NeckThoracic

Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Ovarian Neoplasms

NCT05217940 2025-08-22

SWAN

Phase NA Recruiting

300 enrolled

Gastrointestinal

Anus Neoplasms

NCT03061435 2025-05-16

Vulvar-AIN

Phase NA Recruiting

110 enrolled

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vulvar Neoplasms

NCT06263088 2025-05-07

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

Phase NA Recruiting

200 enrolled

EndocrineGastrointestinalNET

Anus Neoplasms, Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neuroendocrine Tumors

NCT04462042 2025-04-03